R. Andrew's most recent trade in Invesco Ltd was a trade of 156,007 Common Shares done at an average price of $27.0 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Invesco Ltd | Andrew R. Schlossberg | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.01 per share. | 02 Jul 2026 | 156,007 | 742,708 (0%) | 0% | 27.0 | 4,213,749 | Common Shares |
| ARKO Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 5,821 | 195,415 | - | - | Restricted Stock Units | |
| ARKO Petroleum Corp Ordinary | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 1,029 | 8,588 | - | 0 | Class A common Stock, par value $0.0001 per share | |
| Plus Therapeutics Inc | Ronald A. Andrews | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 922 | 922 (0%) | 0% | 0 | Common Stock | |
| Plus Therapeutics Inc | Ronald A. Andrews | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 922 | 2,764 | - | - | Restricted Stock Units | |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Grant, award, or other acquisition of securities at price $ 19.86 per share. | 01 Jul 2026 | 881 | 10,425 (0%) | 0% | 19.9 | 17,493 | Common Stock, par value $0.01 per share |
| TREX Co. Inc | B. Andrew Rose | Director | Grant, award, or other acquisition of securities at price $ 48.69 per share. | 01 Jul 2026 | 526 | 15,409 (0%) | 0% | 48.7 | 25,611 | Common Stock |
| Chart Ind Inc | Andrew R. Cichocki | Director, Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 191 | 3,846 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Dynatrace Inc | George Andrew Riedel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 10,476 | 10,476 | - | - | Restricted Stock Units | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 5,000 | 34,444 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.27 per share. | 30 Jun 2026 | 5,000 | 46,514 (0%) | 0% | 52.3 | 261,350 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 311.72 per share. | 30 Jun 2026 | 1,119 | 44,895 (0%) | 0% | 311.7 | 348,815 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 312.28 per share. | 30 Jun 2026 | 1,081 | 43,814 (0%) | 0% | 312.3 | 337,573 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 315.78 per share. | 30 Jun 2026 | 900 | 42,114 (0%) | 0% | 315.8 | 284,200 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 313.46 per share. | 30 Jun 2026 | 700 | 43,114 (0%) | 0% | 313.5 | 219,420 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 317.15 per share. | 30 Jun 2026 | 600 | 41,514 (0%) | 0% | 317.2 | 190,291 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 308.99 per share. | 30 Jun 2026 | 396 | 46,118 (0%) | 0% | 309.0 | 122,359 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Other type of transaction at price $ 160.71 per share. | 30 Jun 2026 | 132 | 41,514 (0%) | 0% | 160.7 | 21,214 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 310.20 per share. | 30 Jun 2026 | 104 | 46,014 (0%) | 0% | 310.2 | 32,261 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 314.58 per share. | 30 Jun 2026 | 100 | 43,014 (0%) | 0% | 314.6 | 31,458 | Common Stock |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 19.96 per share. | 25 Jun 2026 | 2,832 | 9,544 (0%) | 0% | 20.0 | 56,522 | Common Stock, par value $0.01 per share |
| Arvinas Inc | Andrew R. Saik | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.16 per share. | 24 Jun 2026 | 5,696 | 187,432 (0%) | 0% | 8.2 | 46,474 | Common Stock |
| Wealthfront Corp | Andrew S. Rachleff | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 19,446 | 19,446 | - | - | Restricted Stock Units | |
| Lovesac Co | Andrew R. Heyer | Director | Purchase of securities on an exchange or from another person at price $ 14.68 per share. | 18 Jun 2026 | 30,000 | 293,259 (2%) | 0% | 14.7 | 440,400 | Common Stock, par value $0.00001 |
| Olema Pharma Inc | Andrew S. Rappaport | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 29,500 | 29,500 | - | - | Stock Option (right to buy) | |
| Cullinan Oncology Inc | Andrew R. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 21,781 | 21,781 | - | - | Stock Option (Right to Buy) | |
| OneSpaWorld Holdings Ltd | Andrew R. Heyer | Director | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 15 Jun 2026 | 20,000 | 489,817 (0%) | 0% | 26.0 | 520,800 | Common Shares |
| Milestone Pharma Inc | Andrew R. Saik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Zevia PBC (Class A) | Andrew Ruben | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 72,464 | 299,432 | - | 0 | Class A Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jun 2026 | 1,500 | 3,872,943 (219%) | 0% | 0 | Class A-1 Common Stock | |
| Lovesac Co | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 7,947 | 15,894 | - | - | Restricted Stock Units | |
| Lovesac Co | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 7,947 | 7,947 | - | - | Restricted Stock Units | |
| Lovesac Co | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 6,308 | 263,259 (1%) | 0% | 0 | Common Stock, par value $0.00001 | |
| Lovesac Co | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 6,308 | 256,951 (1%) | 0% | 0 | Common Stock, par value $0.00001 | |
| Lovesac Co | Andrew R. Heyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 6,308 | 0 | - | - | Restricted Stock Units | |
| Lovesac Co | Andrew R. Heyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 6,308 | 0 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Andrew G. Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 40,926 | 0 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Andrew G. Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 40,926 | 115,544 | - | - | Common Stock | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 117.94 per share. | 05 Jun 2026 | 15,800 | 753,281 (1%) | 0% | 117.9 | 1,863,520 | Common Stock |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.11 per share. | 05 Jun 2026 | 9,988 | 743,293 (1%) | 0% | 119.1 | 1,189,670 | Common Stock |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 116.97 per share. | 05 Jun 2026 | 6,900 | 769,081 (1%) | 0% | 117.0 | 807,094 | Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 78,930 | 78,930 | - | - | Restricted Stock Unit (RSU) | |
| ARKO Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 21,262 | 189,594 | - | - | Restricted Stock Units | |
| Sanara MedTech Inc | Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 5,539 | 28,740 | - | 0 | Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2026 | 1,500 | 3,874,443 (219%) | 0% | 0 | Class A-1 Common Stock | |
| J.Jill Inc | Andrew Rolfe | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jun 2026 | 8,341 | 19,342 (0%) | 0% | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | Andrew R. Morse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 20,592 | 193,556 (0%) | 0% | 0 | Common Stock | |
| Figma Inc Ordinary Shares | Andrew Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 12,415 | 12,415 | - | 0 | Class A Common Stock | |
| Lincoln National Corp | Andrew D. Rallis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.63 per share. | 01 Jun 2026 | 20,052 | 162,530 (0%) | 0% | 34.6 | 694,401 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 5,000 | 39,444 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.27 per share. | 01 Jun 2026 | 5,000 | 46,382 (0%) | 0% | 52.3 | 261,350 | Common Stock |
| Tamboran Resources Corp | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 2,975 | 14,295 | - | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 225.97 per share. | 01 Jun 2026 | 1,432 | 43,782 (0%) | 0% | 226.0 | 323,585 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 229.47 per share. | 01 Jun 2026 | 1,216 | 41,582 (0%) | 0% | 229.5 | 279,033 | Common Stock |
| Kimball Electronics Inc | Andrew D. Regrut | VP IR & Strategy, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 1,052 | 5,836 (0%) | 0% | 0 | Common Stock | |
| Kimball Electronics Inc | Andrew D. Regrut | VP IR & Strategy, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 1,052 | 5,295 | - | - | Restricted Shares | |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 225.20 per share. | 01 Jun 2026 | 677 | 45,214 (0%) | 0% | 225.2 | 152,459 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 228.57 per share. | 01 Jun 2026 | 584 | 42,798 (0%) | 0% | 228.6 | 133,487 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 223.95 per share. | 01 Jun 2026 | 491 | 45,891 (0%) | 0% | 223.9 | 109,958 | Common Stock |
| Kimball Electronics Inc | Andrew D. Regrut | VP IR & Strategy, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.60 per share. | 01 Jun 2026 | 457 | 5,379 (0%) | 0% | 25.6 | 11,701 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 226.78 per share. | 01 Jun 2026 | 400 | 43,382 (0%) | 0% | 226.8 | 90,712 | Common Stock |
| Ligand Pharma Inc (Class B) | Andrew Reardon | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 230.41 per share. | 01 Jun 2026 | 200 | 41,382 (0%) | 0% | 230.4 | 46,082 | Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 29 May 2026 | 25,000 | 3,875,943 (219%) | 1% | 12.1 | 302,210 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2026 | 2,225 | 3,900,943 (221%) | 0% | 0 | Class A-1 Common Stock | |
| Black Rock Coffee Bar Inc | Andrew Robert Braithwaite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 8,949 | 11,761 | - | 0 | Class A Common Stock | |
| TFS Fin Corp | Andrew James Rubino | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 11,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| TFS Fin Corp | Andrew James Rubino | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.74 per share. | 26 May 2026 | 11,000 | 32,310 (0%) | 0% | 14.7 | 162,140 | Common Stock |
| TFS Fin Corp | Andrew James Rubino | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.97 per share. | 26 May 2026 | 10,406 | 21,904 (0%) | 0% | 16.0 | 166,184 | Common Stock |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2026 | 4,200 | 3,903,168 (221%) | 0% | 0 | Class A-1 Common Stock | |
| Accel Entertainment Inc (Class A1) | Andrew H. Rubenstein | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2026 | 4,000 | 3,907,368 (221%) | 0% | 0 | Class A-1 Common Stock | |
| Tamboran Resources Corp | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2026 | 1,813 | 11,320 | - | 0 | Common Stock | |
| TFS Fin Corp | Andrew James Rubino | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.09 per share. | 26 May 2026 | 594 | 21,310 (0%) | 0% | 16.1 | 9,557 | Common Stock |
| Lincoln National Corp | Andrew D. Rallis | EVP, Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.03 per share. | 24 May 2026 | 32,281 | 182,582 (0%) | 0% | 36.0 | 1,163,084 | Common Stock |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 19.39 per share. | 22 May 2026 | 1,500 | 12,376 (0%) | 0% | 19.4 | 29,079 | Common Stock, par value $0.01 per share |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 18.87 per share. | 22 May 2026 | 500 | 13,876 (0%) | 0% | 18.9 | 9,435 | Common Stock, par value $0.01 per share |
| Trupanion Inc | Darryl Graham Andrew Rawlings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2026 | 312 | 24,838 (0%) | 0% | - | Common Stock | |
| Trupanion Inc | Darryl Graham Andrew Rawlings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2026 | 312 | 2,188 | - | - | Restricted Stock Unit (RSU) | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 50,000 | 2,225,766 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 50,000 | 950,000 | - | - | Restricted Stock Unit Award | |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 263.95 per share. | 21 May 2026 | 5,667 | 2,209,666 (0%) | 0% | 263.9 | 1,495,785 | Common Stock, par value $.01 per share |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 263.10 per share. | 21 May 2026 | 5,227 | 2,215,333 (0%) | 0% | 263.1 | 1,375,238 | Common Stock, par value $.01 per share |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 261.95 per share. | 21 May 2026 | 5,206 | 2,220,560 (0%) | 0% | 262.0 | 1,363,726 | Common Stock, par value $.01 per share |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 264.97 per share. | 21 May 2026 | 3,600 | 2,206,066 (0%) | 0% | 265.0 | 953,908 | Common Stock, par value $.01 per share |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 265.61 per share. | 21 May 2026 | 300 | 2,205,766 (0%) | 0% | 265.6 | 79,684 | Common Stock, par value $.01 per share |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2026 | 160,000 | 497,503 (1%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2026 | 160,000 | 160,000 (0%) | 0% | 0 | Common Stock | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Purchase of securities on an exchange or from another person at price $ 4.17 per share. | 19 May 2026 | 7,100 | 33,333 (1%) | 0% | 4.2 | 29,607 | Common stock, par value $0.0001 |
| Plus Therapeutics Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 3,686 | 3,686 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 3,686 | 3,686 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Andrew R. Boll | PRESIDENT AND CFO | Purchase of securities on an exchange or from another person at price $ 29.90 per share. | 14 May 2026 | 3,500 | 814,679 (3%) | 0% | 29.9 | 104,650 | Common Stock |
| Plus Therapeutics Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 1,600 | 1,600 | - | - | Stock Option (Right to Buy) | |
| biote Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Andrew R. Neill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2026 | 64,027 | 0 | - | - | Warrants (Right to Buy) | |
| Shattuck Labs Inc | Andrew R. Neill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.08 per share. | 12 May 2026 | 64,027 | 292,251 | - | 1.1 | 69,444 | Common Stock |
| biote Corp (Class A) | Andrew R. Heyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 35,259 | 81,382 | - | - | Deferred Settlement RSU | |
| International Paper | David Andrew Robbie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 5,298 | 14,002 (0%) | 0% | 0 | Common Stock | |
| International Paper | David Andrew Robbie | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.47 per share. | 12 May 2026 | 1,233 | 12,769 (0%) | 0% | 32.5 | 40,036 | Common Stock |
| Arvinas Inc | Andrew R. Saik | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.94 per share. | 11 May 2026 | 11,139 | 193,128 (0%) | 0% | 9.9 | 110,693 | Common Stock |
| 1stdibs.com Inc | Andrew G. Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2026 | 26,798 | 26,798 | - | - | Restricted Stock Units | |
| Alpine Income Property Trust Inc | Andrew C. Richardson | Director | Sale of securities on an exchange or to another person at price $ 19.35 per share. | 08 May 2026 | 3,000 | 14,376 (0%) | 0% | 19.3 | 58,036 | Common Stock, par value $0.01 per share |
| Sterling infra Inc | B. Andrew Rose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 181 | 654 (0%) | 0% | 0 | Common Stock |